The addition of lithium to carbamazepine. Antidepressant efficacy in treatment-resistant depression.
about
Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysisSignalling pathways in the brain: cellular transduction of mood stabilisation in the treatment of manic-depressive illness.The myth of attention deficit-hyperactivity disorder: symptoms resulting from multiple causes.Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder.What makes a drug a primary mood stabilizer?Bipolar depression: criteria for treatment selection, definition of refractoriness, and treatment options.Valproate.Antidepressants in bipolar disorder: the case for caution.Mechanisms of the psychotropic action of lithium and carbamazepine.Clinical and biochemical aspects of depressive disorders: III. Treatment and controversies.Treatment of bipolar depression: focus on pharmacologic therapies.Polytherapy in bipolar disorder.New approaches for the management of bipolar disorder: role of sublingual asenapine in the treatment of mania.Treatment of acute bipolar depression: a review of the literature.Evidence for the activity of lamotrigine at 5-HT(1A) receptors in the mouse forced swimming testAugmentation of valproate with lithium in a case of rapid cycling affective disorder.Treatment-resistant depression: a critique of current approaches.Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder
P2860
Q33529314-816025CB-8BF7-4773-AFA9-8CA6C50FC3A5Q33809252-7CC52EA8-AE0C-4AFF-BD65-188FF41DD775Q33974807-F4CE64CF-A219-408F-A490-6EF0342FDB34Q34547920-1D127455-7544-4314-B04E-1103DF6FCCB2Q34622357-E3816CCB-7F26-4F3E-8D44-3F8169EC8D85Q35101637-533DEFD2-4B6D-4460-B300-A33E3D85D42BQ35142736-189392DF-BF89-48B2-8E1F-94006477942BQ35592492-198DCD08-8585-4425-8B37-431E5F7C4F5DQ35655710-C9550B0A-CA72-454C-94E5-3E1BDA6CB09FQ36106487-2C224F57-07FD-48A3-8F59-FDC72408D35EQ36106769-FD9697B1-50E5-4ADD-9AD5-B859AD041F13Q36361982-F25B96F4-EDFA-465F-9466-8AD73116295BQ36929705-C70ADB73-9948-4E81-BCA7-F40DDD3B9A51Q40954013-AB2712BE-2A20-482F-A442-6968CBEB7D61Q42257957-6A10F302-1503-4037-AB97-7C315A290B28Q45265949-1B1C7872-80CB-4FCB-8761-5F0FB502A01AQ52882661-A810A6BE-05B9-4AC2-826A-0ACE701D5E0CQ57244668-9BD61E3F-F9A0-4279-9DC8-33A43D704FFF
P2860
The addition of lithium to carbamazepine. Antidepressant efficacy in treatment-resistant depression.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
The addition of lithium to car ...... reatment-resistant depression.
@en
The addition of lithium to car ...... reatment-resistant depression.
@nl
type
label
The addition of lithium to car ...... reatment-resistant depression.
@en
The addition of lithium to car ...... reatment-resistant depression.
@nl
prefLabel
The addition of lithium to car ...... reatment-resistant depression.
@en
The addition of lithium to car ...... reatment-resistant depression.
@nl
P1433
P1476
The addition of lithium to car ...... reatment-resistant depression.
@en
P2093
Kramlinger KG
P304
P356
10.1001/ARCHPSYC.1989.01810090036007
P407
P577
1989-09-01T00:00:00Z